BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Gilead Sciences, Inc. 

333 Lakeside Drive

Foster City  California  94404  U.S.A.
Phone: 800-GILEAD-5 or 650-574-3000 Fax: 650-522-5800


SEARCH JOBS




Gilead Sciences is a biopharmaceutical company that discovers, develops, and commercializes innovative therapeutics in areas of unmet medical need.The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Australia.


 Key Statistics


Email:
Ownership: Public

Web Site: Gilead
Employees: 4,000
Symbol: GILD
 



Industry
Biotechnology






 Company News
Gilead (GILD) To Present At The Cowen and Company 35th Annual Health Care Conference On Tuesday, March 3 3/3/2015 11:58:04 AM
Gilead (GILD) Announces Phase 3 Results For Investigational Once-Daily Single Tablet HIV Regimen Containing Tenofovir Alafenamide (TAF) 2/27/2015 10:40:52 AM
Gilead (GILD) Announces SVR12 Rates From Phase III Study Evaluating Harvoni For The Treatment Of Chronic Hepatitis C In Patients Co-Infected With HIV 2/27/2015 6:18:07 AM
Gilead (GILD)'s Harvoni Achieves 96% Cure Rate in Patients With Hepatitis C and HIV 2/27/2015 6:16:45 AM
Gilead (GILD) Holds Cash Overseas to Save Billions on Taxes 2/27/2015 6:10:10 AM
Gilead (GILD) Announces Preclinical Data For An Investigational TLR7 Agonist In SIV-Infected, Virally Suppressed Monkeys 2/26/2015 9:48:55 AM
Gilead (GILD) To Present At The RBC Capital Markets 2015 Healthcare Conference On Wednesday, February 25 2/25/2015 11:06:03 AM
Mylan Inc. (MYL) Signs Exclusive Agreement With Gilead (GILD) To Distribute Sovaldi And Harvoni In India 2/23/2015 7:04:35 AM
Critics Attack as Gilead (GILD) Has a Pill to Stop HIV, But Why Isn't Anyone Taking It? 2/19/2015 6:59:56 AM
ViiV Healthcare Wins for Corporate Reputation With Patients While Gilead (GILD) Freefalls Down List 2/16/2015 6:20:44 AM
12345678910...